‘Game-changing’ gender quotas introduced by Australian research agency nature.com/articles/d4158…

Today, we’re introducing a new model that eliminates accept/reject decisions. By publishing every paper with eLife reviews as a Reviewed Preprint, we plan to restore autonomy to authors, ensuring that they will be judged by what, not where, they publish. elifesciences.org/inside-elife/5…

Welcome to #Australia

bbc.com/news/health-63…

Me when my experiments don't work...

Happy and excited to be part of this interesting study, showing novel functions for circular RNAs in oncogenesis Centre for Cancer Biology UniSA

Does winning a Nobel prize make you less productive? Do you get ‘Nobelitis’? Here’s what it did to me | Paul Nurse theguardian.com/commentisfree/…

Delighted to share that my research proposal has been selected for funding through the NHMRC Ideas Grant! This opportunity will enable me to explore innovative ideas in Immunology. Thank you to everyone who supported me along the way. Stay tuned for exciting updates!

Delighted to share my first co-corresponding research article published in the Journal of Clinical Immunology! link.springer.com/article/10.100… Thanks to the research team, mentors, and colleagues for their support. Stay tuned for more exciting updates! Centre for Cancer Biology UniSA

Excited to be part of this massive international effort, leveraging the power of artificial intelligence in small molecule discovery. Centre for Cancer Biology UniSA Atomwise nature.com/articles/s4159…

Bioinformatics

#AcademicTwitter Yep! #phdlife #phdvoice

Excited to share my latest research in immunodeficiencies! We’ve uncovered the impact of IKKα kinase deficiency in humans for the first time. Huge thanks to all co-authors for their contributions. Centre for Cancer Biology UniSA UniSA Research nature.com/articles/s4146…

newsweek.com/coffee-drinkin…

A novel #MachineLearning framework—Mal-ID—can decipher an individual’s immune system’s record of past infections and diseases, according to a new Science study, providing a powerful tool with the potential for diagnosing autoimmune disorders, viral infections, and vaccine

I am honoured and humbled to receive “The Isil Berat Barlan Award in Primary Immunodeficiency Diseases” given by The Turkish Society of Immunology, together with Prof Talal Chatila from Harvard Medical School, in honour of the late Prof. Isil Berat Barlan.

As a German, for a personal meeting 12 means 12 but for a professional meeting 12 means be 5 minutes early. Any alternative interpretation hurts my little German brain.